1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Narcolepsy Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Narcolepsy Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increase in the prevalence of sleep disorders
- 5.1.2 Growing awareness of narcolepsy symptoms
5.2 Market Opportunities
- 5.2.1 Growth in narcolepsy diagnostic services
- 5.2.2 Expansion in treatment options
5.3 Future Trends
- 5.3.1 Development of personalized treatment plans
- 5.3.2 Increase in adoption of cognitive-behavioral therapy
5.4 Impact of Drivers and Restraints
6. North America Narcolepsy Market Regional Analysis
6.1 North America Narcolepsy Market Overview
6.2 North America Narcolepsy Market Revenue 2016-2027 (US$ Million)
6.3 North America Narcolepsy Market Forecast Analysis
7. North America Narcolepsy Market Analysis – by Type
7.1 Narcolepsy with Cataplexy
- 7.1.1 Overview
- 7.1.2 Narcolepsy with Cataplexy: North America Narcolepsy Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Narcolepsy without Cataplexy
- 7.2.1 Overview
- 7.2.2 Narcolepsy without Cataplexy: North America Narcolepsy Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Secondary Narcolepsy
- 7.3.1 Overview
- 7.3.2 Secondary Narcolepsy: North America Narcolepsy Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Narcolepsy Market Analysis – by Product
8.1 Central Nervous System Stimulants
- 8.1.1 Overview
- 8.1.2 Central Nervous System Stimulants: North America Narcolepsy Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Sodium Oxybate
- 8.2.1 Overview
- 8.2.2 Sodium Oxybate: North America Narcolepsy Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Antidepressants
- 8.3.1 Overview
- 8.3.2 Antidepressants: North America Narcolepsy Market – Revenue and Forecast to 2027 (US$ Million)
9. North America Narcolepsy Market Analysis – by Distribution Channel
9.1 Hospital Pharmacies
- 9.1.1 Overview
- 9.1.2 Antidepressants: North America Narcolepsy Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Retail Pharmacies
- 9.2.1 Overview
- 9.2.2 Antidepressants: North America Narcolepsy Market – Revenue and Forecast to 2027 (US$ Million)
10. North America Narcolepsy Market – North America Analysis
10.1 North America
- 10.1.1 North America Narcolepsy Market Breakdown, by Key
Country, 2019 and 2027 (%)
- 10.1.1.1 North America Narcolepsy Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Narcolepsy Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.1.1 US: North America Narcolepsy Market Breakdown, by Type
- 10.1.1.1.2 US: North America Narcolepsy Market Breakdown, by Product
- 10.1.1.1.3 US: North America Narcolepsy Market Breakdown, by Distribution Channel
- 10.1.1.2 Canada:
North America Narcolepsy Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.2.1 Canada: North America Narcolepsy Market Breakdown, by Type
- 10.1.1.2.2 Canada: North America Narcolepsy Market Breakdown, by Product
- 10.1.1.2.3 Canada: North America Narcolepsy Market Breakdown, by Distribution Channel
- 10.1.1.3 Mexico :
North America Narcolepsy Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.3.1 Mexico : North America Narcolepsy Market Breakdown, by Type
- 10.1.1.3.2 Mexico : North America Narcolepsy Market Breakdown, by Product
- 10.1.1.3.3 Mexico : North America Narcolepsy Market Breakdown, by Distribution Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Narcolepsy Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Teva Pharmaceutical Industries Ltd.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Jazz Pharmaceuticals plc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Arena Pharmaceuticals, Inc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Graymark Healthcare, Inc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Novartis AG
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Takeda Pharmaceutical Company Limited
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Mylan N.V.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 BIOPROJET
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Shionogi & Co., Ltd.
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Ligand Pharmaceuticals, Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For North America Narcolepsy Market
